Who may benefit from a high-dose flu shot this season

Federal recommendations for the 2025-26 season say adults 65 and older should preferentially receive one of three enhanced influenza vaccines, including the high-dose version. If one of those is not available, any age-appropriate flu vaccine can still be used. For other adults, there is no general preference for high-dose vaccines over standard-dose products. The goal is protection against influenza, not finding a single best shot for every person.

What happened

A recent Washington Post report revisited the choice between high-dose and standard-dose flu vaccines as seasonal vaccination gets underway. The article focused on what experts tell patients who are trying to decide whether the higher-antigen shot is worth seeking out. That question matters because flu vaccination is one of the main tools used to reduce illness, hospitalization, and complications during the fall and winter respiratory season.

CDC guidance says routine annual influenza vaccination is recommended for everyone 6 months and older without a contraindication, with vaccination ideally offered in September or October for most people. For adults 65 and older, the agency says any one of three enhanced vaccines is preferred: high-dose inactivated influenza vaccine, recombinant influenza vaccine, or adjuvanted inactivated influenza vaccine. The same guidance notes that the strongest body of data is for the high-dose product, although direct comparisons among the three enhanced options are limited.

Why it matters

Influenza can be especially serious for people whose immune response to vaccination may be weaker. The high-dose vaccine was developed to deliver more antigen than a standard flu shot, with the aim of stimulating a stronger immune response. It is not a different kind of protection in the sense of preventing a different virus; it is still a seasonal flu vaccine, just formulated differently.

That distinction matters because some readers may assume that a higher-dose vaccine is automatically better for everyone. The evidence does not support that leap. Instead, the current federal recommendation reflects a balance of data showing greater potential benefit in older adults, along with the practical reality that multiple enhanced options exist and availability can vary by pharmacy or clinic.

What the evidence actually shows

Research summarized in PubMed-indexed reviews has generally found that high-dose influenza vaccines produce stronger antibody responses than standard-dose vaccines in older adults, and some analyses have found fewer laboratory-confirmed influenza infections, influenza-related hospitalizations, and other serious outcomes in this age group. A 2023 systematic review and meta-analysis reported that high-dose inactivated influenza vaccine provided better protection than standard-dose vaccine against influenza-like illness and influenza-related hospitalizations in adults 65 and older, with supportive observational data across multiple seasons. Earlier meta-analyses reached similar conclusions about higher immunogenicity and better efficacy in older adults.

At the same time, evidence quality and study design still matter. Some of the strongest findings come from randomized trials, while other results come from observational studies that can be affected by differences between the groups being compared. That means the overall pattern points in one direction, but it does not prove that high-dose vaccine is the only meaningful choice or that it will prevent flu equally well for every individual.

The FDA lists Fluzone High-Dose as a vaccine indicated for active immunization against influenza A and B strains contained in the vaccine. That tells patients what the product is approved to do, but it does not by itself establish superiority over other vaccines. For that, clinicians look to comparative effectiveness data and ACIP guidance.

What remains uncertain

One unresolved issue is how the three enhanced options compare with one another. CDC says the data support greater potential benefit for high-dose, adjuvanted, and recombinant vaccines versus standard-dose unadjuvanted products in adults 65 and older, but comparisons among the enhanced vaccines are limited. In plain language: there is reason to favor an enhanced vaccine in this age group, yet the evidence does not clearly rank one enhanced option as universally best.

Another uncertainty is how much benefit any one season’s vaccine will offer, because flu viruses change and vaccine performance varies from year to year. A vaccine that performed well in past studies may not deliver exactly the same result every season. That is one reason experts emphasize getting vaccinated at all rather than waiting for the perfect product.

It is also worth noting that a high-dose vaccine is not the right choice for every person. The CDC’s preference list is specific to adults 65 and older. For other adults, children, and many people with chronic medical conditions, the recommended approach is to get an age-appropriate influenza vaccine rather than chasing one formulation over another.

Practical context for this season

If you are 65 or older, a high-dose flu shot is a reasonable option to ask about, especially if your pharmacy or clinic has it in stock. But the CDC preference is not limited to the high-dose product alone; recombinant and adjuvanted vaccines are also preferred choices in this age group. If one is unavailable, the guidance is to use another age-appropriate flu vaccine rather than skip vaccination altogether.

If you are younger than 65, the main takeaway is simpler: get vaccinated with an age-appropriate flu shot when it becomes available. For most healthy adults, there is no recommendation that you seek out a high-dose product. And even among people who qualify for an enhanced vaccine, the most important step is receiving a vaccine on time rather than delaying for a specific brand.

When to check with a clinician

Most people can discuss flu vaccine choice during a routine visit or at a pharmacy. It is especially useful to ask if you have a history of severe allergic reaction to a vaccine, are immunocompromised, are pregnant, or have another medical issue that affects vaccine selection. If you develop symptoms that could signal flu complications, such as trouble breathing, chest pain, confusion, bluish lips, or dehydration, seek medical care promptly.

For everyone else, the seasonal decision is less about finding a perfect flu shot and more about getting a timely one. High-dose vaccine may offer an advantage for some older adults, but the broader public-health message remains the same: vaccination is still the best-established way to lower flu risk each season.